4 结果
The present invention relates to compounds of the formula, ##STR2## where R.sup.1 is hydrogen, (C.sub.1 -C.sub.6)alkyl, (C.sub.3 -C.sub.6)alkenyl, (C.sub.3 -C.sub.6)alkynyl, aryl(C.sub.1 -C.sub.6)alkyl, (C.sub.1 -C.sub.6)alkylcarbonyl, formyl, (C.sub.1 -C.sub.6)alkoxycarbonyl, aryl(C.sub.1
The present invention relates to compounds of the formula, ##STR2## where R.sup.1 is hydrogen, (C.sub.1 -C.sub.6)alkyl, (C.sub.3 -C.sub.6)alkenyl, (C.sub.3 -C.sub.6)alkynyl, aryl(C.sub.1 -C.sub.6)alkyl, (C.sub.1 -C.sub.6)alkylcarbonyl, formyl, (C.sub.1 -C.sub.6)alkoxycarbonyl, aryl (C.sub.1
The present invention relates to compounds of the formula, ##STR2## where R.sup.1 is hydrogen, (C.sub.1 -C.sub.6)alkyl, (C.sub.3 -C.sub.6)alkenyl, (C.sub.3 -C.sub.6)alkynyl, aryl(C.sub.1 -C.sub.6)alkyl, (C.sub.1 -C.sub.6)alkylcarbonyl, formyl, (C.sub.1 -C.sub.6)alkoxycarbonyl, aryl(C.sub.1
FIELD OF THE INVENTION
The present invention relates to therapeutically active quinolinic sulfide derivatives acting as potent and specific antagonists of excitatory amino acids, to a process for preparation and to their use in treatment in neurological disorders.
Particularly, the compounds